ArticleArthritis research & therapy2024

The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study.

Claudia Di Muzio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.